Fertility Market (By Offering: Assisted Reproductive Technology (IVF, Artificial Insemination, Surrogacy, and Others), Fertility Drugs (Gonadotropin, Anti-estrogen, and Others); By End user: Fertility Clinics, Hospitals, and Clinical Research Institutes) - Global Industry Analysis, Market Size, Share, Growth, Trends, Regional Outlook And Forecasts, 2024 - 2033
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions& Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
5.1. Covid-19: fertility Industry Impact
5.2. fertility Business Impact Assessment: Covid-19
5.2.1. Services Challenges/Disruption
5.2.2. Market Trends and fertility Opportunities in the COVID-19 Landscape for Major Markets
5.3. Strategic Measures against Covid-19
5.3.1. Government Support and Initiative to Combat Covid-19
5.3.2. Proposal for fertility Market Players to deal with Covid-19 Pandemic Scenario
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.1.1. Declining fertility rates across the globe
6.1.1.2. Rising number of fertility clinics worldwide, coupled with technological advancements
6.1.2. Market Restraints
6.1.2.1. High procedural cost of assisted reproductive techniques in developed markets
6.1.3. Market Opportunities
6.1.3.1. Use of fertility treatment options by single parents and same-sex couples
7.1. Market Players Landscape
7.1.1. List of Suppliers
7.1.2. List of End-users
8.1. fertility Market, by Offering, 2024-2033
8.1.1. Assisted Reproductive Technology
8.1.1.1. Market Revenue and Forecast (2021-2033)
8.1.1.2. IVF
8.1.1.3. Market Revenue and Forecast (2021-2033)
8.1.1.4. Artificial Insemination
8.1.1.5. Market Revenue and Forecast (2021-2033)
8.1.1.6. Surrogacy
8.1.1.7. Market Revenue and Forecast (2021-2033)
8.1.1.8. Others
8.1.1.9. Market Revenue and Forecast (2021-2033)
8.1.2. Fertility Drugs
8.1.2.1. Market Revenue and Forecast (2021-2033)
8.1.2.2. Gonadotropin
8.1.2.3. Market Revenue and Forecast (2021-2033)
8.1.2.4. Anti-estrogen
8.1.2.5. Market Revenue and Forecast (2021-2033)
8.1.2.6. Others
8.1.2.7. Market Revenue and Forecast (2021-2033)
9.1. fertility Market, by Grade, 2024-2033
9.1.1. Fertility Clinics
9.1.1.1. Market Revenue and Forecast (2021-2033)
9.1.2. Hospitals
9.1.2.1. Market Revenue and Forecast (2021-2033)
9.1.3. Clinical Research Institutes
9.1.3.1. Market Revenue and Forecast (2021-2033)
10.1. North America
10.1.1. Market Revenue Forecast by Offering (2021-2033)
10.1.2. Market Revenue Forecast by End-user(2021-2033)
10.1.3. U.S
10.1.3.1. Market Revenue Forecast (2021-2033)
10.1.4. Canada
10.1.4.1. Market Revenue Forecast (2021-2033)
10.2. Europe
10.2.1. Market Revenue Forecast by Offering (2021-2033)
10.2.2. Market Revenue Forecast by End-user (2021-2033)
10.2.3. UK
10.2.3.1. Market Revenue Forecast (2021-2033)
10.2.4. Germany
10.2.4.1. Market Revenue Forecast (2021-2033)
10.2.5. France
10.2.5.1. Market Revenue Forecast (2021-2033)
10.2.6. Rest of EU
10.2.6.1. Market Revenue Forecast (2021-2033)
10.3. Asia Pacific (APAC)
10.3.1. Market Revenue Forecast by Offering (2021-2033)
10.3.2. Market Revenue Forecast by End-user (2021-2033)
10.3.3. China
10.3.3.1. Market Revenue Forecast (2021-2033)
10.3.4. India
10.3.4.1. Market Revenue Forecast (2021-2033)
10.3.5. Japan
10.3.5.1. Market Revenue Forecast (2021-2033)
10.3.6. Rest of APAC
10.3.6.1. Market Revenue Forecast (2021-2033)
10.4. LATAM
10.4.1. Market Revenue Forecast by Offering (2021-2033)
10.4.2. Market Revenue Forecast by End-user (2021-2033)
10.4.3. Brazil
10.4.3.1. Market Revenue Forecast (2021-2033)
10.4.4. Rest of LATAM
10.4.4.1. Market Revenue Forecast (2021-2033)
10.5. Middle East and Africa (MEA)
10.5.1. Market Revenue Forecast by Offering (2021-2033)
10.5.2. Market Revenue Forecast by End-user (2021-2033)
10.5.3. GCC
10.5.3.1. Market Revenue Forecast (2021-2033)
10.5.4. North Africa
10.5.4.1. Market Revenue Forecast (2021-2033)
10.5.5. South Africa
10.5.5.1. Market Revenue Forecast (2021-2033)
10.5.6. Rest of MEA
10.5.6.1. Market Revenue Forecast (2021-2033)
11.1. Boston IVF Fertility Clinic
11.1.1. Company Overview, Business Information, Regional Presence
11.1.2. Product Portfolio Analysis
11.1.2.1. Product Details, Specification, Application
11.1.3. Revenue, Price, and Gross Margin
11.1.4. Recent Developments and Strategies
11.2. INVO Bioscience
11.2.1. Company Overview, Business Information, Regional Presence
11.2.2. Product Portfolio Analysis
11.2.2.1. Product Details, Specification, Application
11.2.3. Revenue, Price, and Gross Margin
11.2.4. Recent Developments and Strategies
11.3. San Diego Fertility Center
11.3.1. Company Overview, Business Information, Regional Presence
11.3.2. Product Portfolio Analysis
11.3.2.1. Product Details, Specification, Application
11.3.3. Revenue, Price, and Gross Margin
11.3.4. Recent Developments and Strategies
11.4. Celmatix
11.4.1. Company Overview, Business Information, Regional Presence
11.4.2. Product Portfolio Analysis
11.4.2.1. Product Details, Specification, Application
11.4.3. Revenue, Price, and Gross Margin
11.4.4. Recent Developments and Strategies
11.5. FUJIFILM IRVINE SCIENTIFIC
11.5.1. Company Overview, Business Information, Regional Presence
11.5.2. Product Portfolio Analysis
11.5.2.1. Product Details, Specification, Application
11.5.3. Revenue, Price, and Gross Margin
11.5.4. Recent Developments and Strategies
11.6. Carolinas Fertility Institute
11.6.1. Company Overview, Business Information, Regional Presence
11.6.2. Product Portfolio Analysis
11.6.2.1. Product Details, Specification, Application
11.6.3. Revenue, Price, and Gross Margin
11.6.4. Recent Developments and Strategies
11.7. Progyny Inc.
11.7.1. Company Overview, Business Information, Regional Presence
11.7.2. Product Portfolio Analysis
11.7.2.1. Product Details, Specification, Application
11.7.3. Revenue, Price, and Gross Margin
11.7.4. Recent Developments and Strategies
11.8. Cook Medical
11.8.1. Company Overview, Business Information, Regional Presence
11.8.2. Product Portfolio Analysis
11.8.2.1. Product Details, Specification, Application
11.8.3. Revenue, Price, and Gross Margin
11.8.4. Recent Developments and Strategies
11.9. LifeGlobal Group (Cooper Surgical)
11.9.1. Company Overview, Business Information, Regional Presence
11.9.2. Product Portfolio Analysis
11.9.2.1. Product Details, Specification, Application
11.9.3. Revenue, Price, and Gross Margin
11.9.4. Recent Developments and Strategies
12.1. About Us
12.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client